Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis
Top Cited Papers
Open Access
- 1 July 2021
- journal article
- research article
- Published by Elsevier BV in Pharmacological Research
- Vol. 170, 105748
- https://doi.org/10.1016/j.phrs.2021.105748
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial–mesenchymal transitionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Extracellular calcium depletion transiently elevates oxygen consumption in neurosecretory PC12 cells through activation of mitochondrial Na+/Ca2+ exchangeBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancerBritish Journal of Pharmacology, 2010
- Cucurbitacin B Induces Apoptosis by Inhibition of the JAK/STAT Pathway and Potentiates Antiproliferative Effects of Gemcitabine on Pancreatic Cancer CellsCancer Research, 2009
- Cucurbitane-Type Triterpenoids from the Stems of Cucumis meloJournal of Natural Products, 2009
- Pyroptosis: host cell death and inflammationNature Reviews Microbiology, 2009
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast CancerJNCI Journal of the National Cancer Institute, 2008
- Small Cell Lung CancerMayo Clinic Proceedings, 2008
- Cucurbitacins, Cell Adhesion Inhibitors from Conobea scoparioidesJournal of Natural Products, 1994